All Technologies

As a part of our nutraceutical/dietary supplement development program, we found that 50 and 150 mg/kg body weight doses of the bioactive compound N017-0036 and its enriched fraction 1703-F003 respectively improved the ovarian health by increasing the preovulatory follicles and ovulation potential (corpus luteum) at the same time decreasing the cystic follicles. The pure compound N017-0036 alone improves the ovulation independently in the PCOS animal model. The proposed nutraceutical product (1703-F003) development has enormous clinical application and market potential.